However, some studies suggest that Tirzepatide may lead to slightly greater weight loss and improvements in blood sugar control compared to Semaglutide
Semaglutide may improve IBS symptoms by modulating gut motility and potentially reducing abdominal pain and bloating
As the use of GLP-1 receptor agonists, SGLT2 inhibitors, and DPP-4 inhibitors continues to grow, anesthesiologists must remain informed about both the benefits and potential perioperative risks associated with these therapies
PubMed Central , Proceedings of the National Academy of Sciences of the United States of America , vol
Common injection sites include the abdomen, upper arms, and front of the thighs
Its important to clarify that drug tests vary widely in what substances they detect